RXRX

Recursion Pharmaceuticals Inc

May 19 • 04:00PM ET

2.85

-0.04 -1.38 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: SDGR RLAY ABCL BEAM NTLA

| Held by: ARKK VTI XBI VB ARKG IWM VBK VXF IWO IBB

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.20	Insider Own	11.62%	Shs Outstand	524.46M	Perf Week	-9.52%
Market Cap	1.51B	Forward P/E	-	EPS next Y	-0.87	Insider Trans	-2.35%	Shs Float	469.11M	Perf Month	-22.76%
Enterprise Value	925.07M	PEG	-	EPS next Q	-0.24	Inst Own	59.15%	Short Float	36.52%	Perf Quarter	-19.26%
Income	-559.78M	P/S	22.78	EPS this Y	35.88%	Inst Trans	-0.14%	Short Ratio	12.34	Perf Half Y	-31.16%
Sales	66.41M	P/B	1.48	EPS next Y	5.29%	ROA	-42.33%	Short Interest	171.32M	Perf YTD	-30.32%
Book/sh	1.93	P/C	2.29	EPS next 5Y	19.19%	ROE	-57.16%	52W High	7.18 -60.31%	Perf Year	-36.81%
Cash/sh	1.24	P/FCF	-	EPS past 3/5Y	-1.84% -22.39%	ROIC	-52.08%	52W Low	2.80 1.79%	Perf 3Y	-55.68%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	23.30% 79.91%	Gross Margin	-69.58%	Volatility	4.49% 5.52%	Perf 5Y	-86.49%
Dividend TTM	-	EV/Sales	13.93	EPS Y/Y TTM	32.35%	Oper. Margin	-881.32%	ATR (14)	0.18	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	5.47	Sales Y/Y TTM	11.07%	Profit Margin	-842.93%	RSI (14)	32.72	Recom	2.25
Dividend Gr. 3/5Y	- -	Current Ratio	5.47	EPS Q/Q	55.84%	SMA20	-13.45%	Beta	1.02	Target Price	6.64
Payout	-	Debt/Eq	0.07	Sales Q/Q	-56.11%	SMA50	-13.95%	Rel Volume	1.15	Prev Close	2.89
Employees	600	LT Debt/Eq	0.05	Earnings	May 06 BMO	SMA200	-34.55%	Avg Volume	13.88M	Price	2.85
IPO	Apr 16, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	16.98% -60.06%	Trades		Volume	15,914,548	Change	-1.38%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)